ES2362718T3 - Implantes poliméricos bioabsorbibles y un método de uso de los mismos para crear oclusiones. - Google Patents
Implantes poliméricos bioabsorbibles y un método de uso de los mismos para crear oclusiones. Download PDFInfo
- Publication number
- ES2362718T3 ES2362718T3 ES02706247T ES02706247T ES2362718T3 ES 2362718 T3 ES2362718 T3 ES 2362718T3 ES 02706247 T ES02706247 T ES 02706247T ES 02706247 T ES02706247 T ES 02706247T ES 2362718 T3 ES2362718 T3 ES 2362718T3
- Authority
- ES
- Spain
- Prior art keywords
- spirals
- biocompatible
- aneurysms
- spiral
- aneurysm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000007943 implant Substances 0.000 title claims description 29
- 238000000034 method Methods 0.000 title description 16
- 230000000975 bioactive effect Effects 0.000 claims abstract description 79
- 229920000642 polymer Polymers 0.000 claims abstract description 39
- 239000003102 growth factor Substances 0.000 claims abstract description 20
- 230000001413 cellular effect Effects 0.000 claims abstract description 11
- 229920001577 copolymer Polymers 0.000 claims abstract description 10
- 229920000954 Polyglycolide Polymers 0.000 claims abstract description 9
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims abstract description 9
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims abstract description 9
- 229920001432 poly(L-lactide) Polymers 0.000 claims abstract description 9
- 230000028709 inflammatory response Effects 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 238000002513 implantation Methods 0.000 claims abstract description 4
- -1 polycaprolactive Polymers 0.000 claims abstract 2
- 229910052751 metal Inorganic materials 0.000 claims description 78
- 239000002184 metal Substances 0.000 claims description 78
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims description 6
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 5
- 108090000695 Cytokines Proteins 0.000 claims description 3
- 102000004127 Cytokines Human genes 0.000 claims description 3
- 238000011065 in-situ storage Methods 0.000 claims description 3
- 238000001125 extrusion Methods 0.000 claims description 2
- 206010002329 Aneurysm Diseases 0.000 abstract description 178
- 239000000463 material Substances 0.000 abstract description 49
- 210000002808 connective tissue Anatomy 0.000 abstract description 18
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 abstract description 8
- 230000003073 embolic effect Effects 0.000 abstract description 7
- 230000007774 longterm Effects 0.000 abstract description 7
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 abstract description 6
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 abstract description 6
- 230000009466 transformation Effects 0.000 abstract description 6
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 230000002792 vascular Effects 0.000 abstract description 3
- 238000012276 Endovascular treatment Methods 0.000 abstract description 2
- 229920002732 Polyanhydride Polymers 0.000 abstract 1
- 229920000331 Polyhydroxybutyrate Polymers 0.000 abstract 1
- 230000003118 histopathologic effect Effects 0.000 abstract 1
- 238000007917 intracranial administration Methods 0.000 abstract 1
- 239000005015 poly(hydroxybutyrate) Substances 0.000 abstract 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 abstract 1
- 229920000515 polycarbonate Polymers 0.000 abstract 1
- 239000004417 polycarbonate Substances 0.000 abstract 1
- 239000000622 polydioxanone Substances 0.000 abstract 1
- 239000004633 polyglycolic acid Substances 0.000 abstract 1
- 210000003739 neck Anatomy 0.000 description 45
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 27
- MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 21
- 210000001519 tissue Anatomy 0.000 description 20
- 230000010102 embolization Effects 0.000 description 19
- 210000001367 artery Anatomy 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 201000008450 Intracranial aneurysm Diseases 0.000 description 11
- 230000035876 healing Effects 0.000 description 11
- 230000003287 optical effect Effects 0.000 description 11
- 229910052697 platinum Inorganic materials 0.000 description 11
- 208000007536 Thrombosis Diseases 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 208000031481 Pathologic Constriction Diseases 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 230000036262 stenosis Effects 0.000 description 7
- 208000037804 stenosis Diseases 0.000 description 7
- 206010016654 Fibrosis Diseases 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000004761 fibrosis Effects 0.000 description 6
- 231100000241 scar Toxicity 0.000 description 6
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 241000282887 Suidae Species 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 210000003792 cranial nerve Anatomy 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000009513 drug distribution Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 206010029113 Neovascularisation Diseases 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000002491 angiogenic effect Effects 0.000 description 2
- 210000001168 carotid artery common Anatomy 0.000 description 2
- 230000036755 cellular response Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000000280 densification Methods 0.000 description 2
- 230000036732 histological change Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 230000004941 influx Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
- 238000001793 Wilcoxon signed-rank test Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 208000021328 arterial occlusion Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005520 electrodynamics Effects 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 1
- 229960003132 halothane Drugs 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005399 mechanical ventilation Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009424 thromboembolic effect Effects 0.000 description 1
- 230000002885 thrombogenetic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
- 229960001600 xylazine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/12145—Coils or wires having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/082—Inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable or resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/785,743 US7070607B2 (en) | 1998-01-27 | 2001-02-16 | Bioabsorbable polymeric implants and a method of using the same to create occlusions |
| US785743 | 2001-02-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2362718T3 true ES2362718T3 (es) | 2011-07-12 |
Family
ID=25136501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES02706247T Expired - Lifetime ES2362718T3 (es) | 2001-02-16 | 2002-02-11 | Implantes poliméricos bioabsorbibles y un método de uso de los mismos para crear oclusiones. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7070607B2 (ja) |
| EP (2) | EP1359953B1 (ja) |
| JP (1) | JP4630525B2 (ja) |
| AT (1) | ATE509644T1 (ja) |
| AU (1) | AU2002240349A1 (ja) |
| CA (1) | CA2437694C (ja) |
| ES (1) | ES2362718T3 (ja) |
| WO (1) | WO2002066091A2 (ja) |
Families Citing this family (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6200312B1 (en) * | 1997-09-11 | 2001-03-13 | Vnus Medical Technologies, Inc. | Expandable vein ligator catheter having multiple electrode leads |
| US20070093889A1 (en) * | 1999-01-27 | 2007-04-26 | Wu Benjamin M | Non-Fragmenting Low Friction Bioactive Absorbable Coils for Brain Aneurysm Therapy |
| US7070607B2 (en) * | 1998-01-27 | 2006-07-04 | The Regents Of The University Of California | Bioabsorbable polymeric implants and a method of using the same to create occlusions |
| US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
| US7266687B2 (en) * | 2001-02-16 | 2007-09-04 | Motorola, Inc. | Method and apparatus for storing and distributing encryption keys |
| US6585754B2 (en) * | 2001-05-29 | 2003-07-01 | Scimed Life Systems, Inc. | Absorbable implantable vaso-occlusive member |
| US7927368B2 (en) * | 2002-03-25 | 2011-04-19 | Kieran Murphy Llc | Device viewable under an imaging beam |
| US20030181810A1 (en) | 2002-03-25 | 2003-09-25 | Murphy Kieran P. | Kit for image guided surgical procedures |
| US9375203B2 (en) | 2002-03-25 | 2016-06-28 | Kieran Murphy Llc | Biopsy needle |
| US7695488B2 (en) * | 2002-03-27 | 2010-04-13 | Boston Scientific Scimed, Inc. | Expandable body cavity liner device |
| WO2004010878A1 (en) | 2002-07-31 | 2004-02-05 | Microvention, Inc. | Three element coaxial vaso-occlusive device |
| DE10237572A1 (de) * | 2002-08-13 | 2004-02-26 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | Stent mit polymerer Beschichtung |
| US7225024B2 (en) * | 2003-09-30 | 2007-05-29 | Cardiac Pacemakers, Inc. | Sensors having protective eluting coating and method therefor |
| US20050107867A1 (en) * | 2003-11-17 | 2005-05-19 | Taheri Syde A. | Temporary absorbable venous occlusive stent and superficial vein treatment method |
| DE10361942A1 (de) * | 2003-12-24 | 2005-07-21 | Restate Patent Ag | Radioopaker Marker für medizinische Implantate |
| ES2357243T3 (es) * | 2004-05-21 | 2011-04-20 | Micro Therapeutics, Inc. | Espirales metálicas entrelazadas con polímeros o fibras biológicos o biodegradables o sintéticos para la embolización de una cavidad corporal. |
| US20060047299A1 (en) * | 2004-08-24 | 2006-03-02 | Ferguson Patrick J | Vascular occlusive wire with extruded bioabsorbable sheath |
| WO2006026412A2 (en) * | 2004-08-31 | 2006-03-09 | Vnus Medical Technologies, Inc. | Apparatus and material composition for permanent occlusion of a hollow anatomical structure |
| WO2006032289A1 (de) | 2004-09-22 | 2006-03-30 | Dendron Gmbh | Medizinisches implantat |
| EP1793743B1 (de) | 2004-09-22 | 2009-11-18 | Dendron GmbH | Vorrichtung zur implantation von mikrowendeln |
| TW200635566A (en) | 2005-01-25 | 2006-10-16 | Vnus Med Tech Inc | Structures for permanent occlusion of a hollow anatomical structure |
| DE102005019782A1 (de) * | 2005-04-28 | 2006-11-09 | Dendron Gmbh | Vorrichtung zur Implantation von Okklusionswendeln mit innenliegendem Sicherungsmittel |
| US20070078479A1 (en) * | 2005-10-04 | 2007-04-05 | Boston Scientific Scimed, Inc. | Self-expanding vaso-occlusive devices with regulated expansion |
| US20080243068A1 (en) * | 2005-12-29 | 2008-10-02 | Kamal Ramzipoor | Methods and apparatus for treatment of venous insufficiency |
| US20070208277A1 (en) * | 2006-03-06 | 2007-09-06 | Rioux Robert F | Vessel volume determination for embolization |
| US8777979B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
| KR20090008347A (ko) | 2006-04-17 | 2009-01-21 | 마이크로 테라퓨틱스 인코포레이티드 | 혈관내 삽입물을 기계적으로 위치설정하는 시스템 및 방법 |
| US9017361B2 (en) | 2006-04-20 | 2015-04-28 | Covidien Lp | Occlusive implant and methods for hollow anatomical structure |
| BRPI0711784B8 (pt) | 2006-06-15 | 2021-06-22 | Microvention Inc | dispositivo de embolização construído de polímero expansível e seu método de preparação |
| EP3009477B1 (en) | 2006-07-20 | 2024-01-24 | Orbusneich Medical Pte. Ltd | Bioabsorbable polymeric composition for a medical device |
| US8460364B2 (en) * | 2006-07-20 | 2013-06-11 | Orbusneich Medical, Inc. | Bioabsorbable polymeric medical device |
| WO2008011614A2 (en) * | 2006-07-20 | 2008-01-24 | Orbusneich Medical, Inc. | Bioabsorbable polymeric medical device |
| US7959942B2 (en) * | 2006-10-20 | 2011-06-14 | Orbusneich Medical, Inc. | Bioabsorbable medical device with coating |
| US8691321B2 (en) * | 2006-10-20 | 2014-04-08 | Orbusneich Medical, Inc. | Bioabsorbable polymeric composition and medical device background |
| MX2009004292A (es) | 2006-10-22 | 2009-08-12 | Idev Technologies Inc | Dispositivos y metodos para el avance de stent. |
| EP3150177B1 (en) | 2006-10-22 | 2021-06-02 | Idev Technologies, Inc. | Methods for securing strand ends and the resulting devices |
| US20080140002A1 (en) * | 2006-12-06 | 2008-06-12 | Kamal Ramzipoor | System for delivery of biologically active substances with actuating three dimensional surface |
| WO2008112435A2 (en) | 2007-03-13 | 2008-09-18 | Micro Therapeutics, Inc. | An implant including a coil and a stretch-resistant member |
| KR20100015521A (ko) | 2007-03-13 | 2010-02-12 | 마이크로 테라퓨틱스 인코포레이티드 | 임플란트, 맨드릴, 및 임플란트 형성방법 |
| US20110130822A1 (en) * | 2007-07-20 | 2011-06-02 | Orbusneich Medical, Inc. | Bioabsorbable Polymeric Compositions and Medical Devices |
| WO2009086208A2 (en) | 2007-12-21 | 2009-07-09 | Microvention, Inc. | Hydrogel filaments for biomedical uses |
| CA2722037C (en) | 2008-04-21 | 2016-03-22 | Nfocus Neuromedical, Inc. | Braid-ball embolic devices and delivery systems |
| US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
| US8298466B1 (en) | 2008-06-27 | 2012-10-30 | Abbott Cardiovascular Systems Inc. | Method for fabricating medical devices with porous polymeric structures |
| RU2011102994A (ru) | 2008-07-22 | 2012-08-27 | Микро Терапьютикс, Инк. (Us) | Устройство для реконструкции сосудов |
| EP2349125B1 (en) * | 2008-10-10 | 2017-04-05 | OrbusNeich Medical, Inc. | Bioabsorbable polymeric medical device |
| WO2010042952A1 (en) * | 2008-10-11 | 2010-04-15 | Orbusneich Medical, Inc. | Bioabsorbable polymeric compositions and medical devices |
| US10639396B2 (en) | 2015-06-11 | 2020-05-05 | Microvention, Inc. | Polymers |
| US9114200B2 (en) | 2009-09-24 | 2015-08-25 | Microvention, Inc. | Injectable hydrogel filaments for biomedical uses |
| CN102573666B (zh) * | 2009-10-21 | 2016-03-16 | 皇家飞利浦电子股份有限公司 | 线圈填充参数的交互式确定 |
| BR112012009287A2 (pt) * | 2009-10-26 | 2017-06-06 | Microvention Inc | dispositivo de embolização feito de polímero expansível |
| ES2534192T3 (es) | 2009-11-09 | 2015-04-20 | Covidien Lp | Características de dispositivo embólico de bola de malla |
| US9468442B2 (en) | 2010-01-28 | 2016-10-18 | Covidien Lp | Vascular remodeling device |
| WO2011094634A1 (en) | 2010-01-28 | 2011-08-04 | Micro Therapeutics, Inc. | Vascular remodeling device |
| US9023095B2 (en) | 2010-05-27 | 2015-05-05 | Idev Technologies, Inc. | Stent delivery system with pusher assembly |
| US8888841B2 (en) | 2010-06-21 | 2014-11-18 | Zorion Medical, Inc. | Bioabsorbable implants |
| US8986369B2 (en) | 2010-12-01 | 2015-03-24 | Zorion Medical, Inc. | Magnesium-based absorbable implants |
| CA2825774C (en) | 2011-02-11 | 2017-02-28 | Frank P. Becking | Two-stage deployment aneurysm embolization devices |
| WO2012134990A1 (en) | 2011-03-25 | 2012-10-04 | Tyco Healthcare Group Lp | Vascular remodeling device |
| WO2012145431A2 (en) | 2011-04-18 | 2012-10-26 | Microvention, Inc. | Embolic devices |
| US9950341B2 (en) * | 2011-07-07 | 2018-04-24 | The Regents Of The University Of California | Systems and methods for fabricating spiral coils with atomized bioactive coatings |
| US9060886B2 (en) | 2011-09-29 | 2015-06-23 | Covidien Lp | Vascular remodeling device |
| US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
| US9011480B2 (en) | 2012-01-20 | 2015-04-21 | Covidien Lp | Aneurysm treatment coils |
| US9687245B2 (en) | 2012-03-23 | 2017-06-27 | Covidien Lp | Occlusive devices and methods of use |
| US8998977B2 (en) | 2012-04-13 | 2015-04-07 | Medtronic Vascular, Inc. | Hollow drug-filled stent and method of forming hollow drug-filled stent |
| US9011884B2 (en) | 2012-04-18 | 2015-04-21 | Microvention, Inc. | Embolic devices |
| EP2861257B1 (en) | 2012-06-14 | 2021-12-08 | Microvention, Inc. | Polymeric treatment compositions |
| CN104717983B (zh) | 2012-10-15 | 2018-09-18 | 微仙美国有限公司 | 聚合治疗组合物 |
| US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
| US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
| US9655999B2 (en) | 2013-03-12 | 2017-05-23 | Carnegie Mellon University | Coated vaso-occlusive device for treatment of aneurysms |
| US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
| CN105142545B (zh) | 2013-03-15 | 2018-04-06 | 柯惠有限合伙公司 | 闭塞装置 |
| JP6401781B2 (ja) | 2013-05-08 | 2018-10-10 | エンボルクス, インク.Embolx, Inc. | 一体型流量調整による経血管的腫瘍塞栓形成の装置及び方法 |
| US9844383B2 (en) | 2013-05-08 | 2017-12-19 | Embolx, Inc. | Devices and methods for low pressure tumor embolization |
| CN104739479B (zh) * | 2013-12-31 | 2017-11-03 | 微创神通医疗科技（上海）有限公司 | 一种弹簧圈及其制备方法 |
| EP3091938B1 (en) * | 2014-01-10 | 2021-04-14 | Nanyang Technological University | Embolic device, an apparatus for embolizing a target vascular site and a method thereof |
| US10124090B2 (en) | 2014-04-03 | 2018-11-13 | Terumo Corporation | Embolic devices |
| US9713475B2 (en) | 2014-04-18 | 2017-07-25 | Covidien Lp | Embolic medical devices |
| CN110433326A (zh) | 2014-04-29 | 2019-11-12 | 微仙美国有限公司 | 包含活性剂的聚合物 |
| US10092663B2 (en) | 2014-04-29 | 2018-10-09 | Terumo Corporation | Polymers |
| WO2016053688A1 (en) | 2014-10-01 | 2016-04-07 | Heartware, Inc. | Backup controller system with updating |
| US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
| US10350382B1 (en) | 2018-06-08 | 2019-07-16 | Embolx, Inc. | High torque catheter and methods of manufacture |
| US9550046B1 (en) | 2016-02-16 | 2017-01-24 | Embolx, Inc. | Balloon catheter and methods of fabrication and use |
| US11464948B2 (en) | 2016-02-16 | 2022-10-11 | Embolx, Inc. | Balloon catheters and methods of manufacture and use |
| US10368874B2 (en) | 2016-08-26 | 2019-08-06 | Microvention, Inc. | Embolic compositions |
| WO2019074965A1 (en) | 2017-10-09 | 2019-04-18 | Microvention, Inc. | EMBOLIC RADIOACTIVE LIQUID |
| US20190247638A1 (en) | 2018-02-13 | 2019-08-15 | Kieran P. Murphy | Delivery system for delivering a drug depot to a target site under image guidance and methods and uses of same |
| CN113855137A (zh) * | 2020-06-30 | 2021-12-31 | 微创神通医疗科技（上海）有限公司 | 医用弹簧圈及其制备方法 |
| US20220249571A1 (en) * | 2021-02-05 | 2022-08-11 | Fluid Biotech Inc. | Neointima formation using mesenchymal stem cells or derivatives thereof |
| US20220313267A1 (en) * | 2021-03-31 | 2022-10-06 | DePuy Synthes Products, Inc. | Bio-absorbable coiled fiber |
| CN113768608B (zh) * | 2021-09-24 | 2023-04-11 | 惠州市顺美医疗科技有限公司 | 一种球形弹簧圈的自动化生产工艺 |
Family Cites Families (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2127903A (en) * | 1936-05-05 | 1938-08-23 | Davis & Geck Inc | Tube for surgical purposes and method of preparing and using the same |
| AT261800B (de) * | 1966-08-22 | 1968-05-10 | Braun Internat Gmbh B | Verfahren zur Herstellung von röhrenförmigen, glatten bzw. mit einem Gewinde versehenen Gewebe-Blutgefäß-Prothesen |
| US5759830A (en) * | 1986-11-20 | 1998-06-02 | Massachusetts Institute Of Technology | Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo |
| US5527337A (en) * | 1987-06-25 | 1996-06-18 | Duke University | Bioabsorbable stent and method of making the same |
| GB2215209B (en) * | 1988-03-14 | 1992-08-26 | Osmed Inc | Method and apparatus for biodegradable, osteogenic, bone graft substitute device |
| US4902508A (en) * | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
| US5843156A (en) | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
| US5141747A (en) * | 1989-05-23 | 1992-08-25 | Minnesota Mining And Manufacturing Company | Denatured collagen membrane |
| JP2930329B2 (ja) * | 1989-09-28 | 1999-08-03 | ソニー株式会社 | 抗血栓性材料 |
| US5386012A (en) * | 1990-02-06 | 1995-01-31 | Strid; Lars | Growth factor in connection with artificial implants |
| US5122136A (en) * | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
| DE4012398A1 (de) * | 1990-04-19 | 1991-10-24 | Waelischmiller Hans Dipl Ing F | Bestrahlungsvorrichtung |
| US5108407A (en) * | 1990-06-08 | 1992-04-28 | Rush-Presbyterian St. Luke's Medical Center | Method and apparatus for placement of an embolic coil |
| US5626863A (en) * | 1992-02-28 | 1997-05-06 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| JPH0549689A (ja) * | 1991-08-20 | 1993-03-02 | Sony Corp | 細胞接着性材料およびその製造方法 |
| US5281422A (en) * | 1991-09-24 | 1994-01-25 | Purdue Research Foundation | Graft for promoting autogenous tissue growth |
| US5304194A (en) * | 1991-10-02 | 1994-04-19 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
| US5261916A (en) * | 1991-12-12 | 1993-11-16 | Target Therapeutics | Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling |
| US5234437A (en) * | 1991-12-12 | 1993-08-10 | Target Therapeutics, Inc. | Detachable pusher-vasoocclusion coil assembly with threaded coupling |
| WO1993015787A1 (en) | 1992-02-12 | 1993-08-19 | Chandler Jerry W | Biodegradable stent |
| US6231881B1 (en) * | 1992-02-24 | 2001-05-15 | Anton-Lewis Usala | Medium and matrix for long-term proliferation of cells |
| US5591224A (en) * | 1992-03-19 | 1997-01-07 | Medtronic, Inc. | Bioelastomeric stent |
| DE4312147C2 (de) * | 1992-04-14 | 1996-01-25 | Olympus Optical Co | Trokar |
| US5272074A (en) * | 1992-04-23 | 1993-12-21 | Mcmaster University | Fibrin coated polymer surfaces |
| WO1994006460A1 (en) * | 1992-09-21 | 1994-03-31 | Vitaphore Corporation | Embolization plugs for blood vessels |
| US5350397A (en) * | 1992-11-13 | 1994-09-27 | Target Therapeutics, Inc. | Axially detachable embolic coil assembly |
| US5250071A (en) * | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
| US5382259A (en) | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
| WO1994011304A1 (en) | 1992-11-12 | 1994-05-26 | Deloro Magnesite Venture Fund | Process for removing metal impurities from calcined magnesite |
| US5275826A (en) * | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
| US6653291B1 (en) | 1992-11-13 | 2003-11-25 | Purdue Research Foundation | Composition and method for production of transformed cells |
| US5690666A (en) | 1992-11-18 | 1997-11-25 | Target Therapeutics, Inc. | Ultrasoft embolism coils and process for using them |
| US5423849A (en) | 1993-01-15 | 1995-06-13 | Target Therapeutics, Inc. | Vasoocclusion device containing radiopaque fibers |
| US5902279A (en) | 1993-04-20 | 1999-05-11 | Advanced Cytometrix, Inc. | Aspiration needle and method |
| WO1994026175A1 (en) | 1993-05-06 | 1994-11-24 | Vitaphore Corporation | Embolization device |
| US5624449A (en) * | 1993-11-03 | 1997-04-29 | Target Therapeutics | Electrolytically severable joint for endovascular embolic devices |
| US5460962A (en) * | 1994-01-04 | 1995-10-24 | Organogenesis Inc. | Peracetic acid sterilization of collagen or collagenous tissue |
| AU1609195A (en) | 1994-02-01 | 1995-08-21 | Kensey Nash Corporation | Percutaneous drug dosing closure system |
| US5942496A (en) | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
| ATE310839T1 (de) | 1994-04-29 | 2005-12-15 | Scimed Life Systems Inc | Stent mit kollagen |
| US5549624A (en) | 1994-06-24 | 1996-08-27 | Target Therapeutics, Inc. | Fibered vasooclusion coils |
| US5522836A (en) * | 1994-06-27 | 1996-06-04 | Target Therapeutics, Inc. | Electrolytically severable coil assembly with movable detachment point |
| US5788979A (en) * | 1994-07-22 | 1998-08-04 | Inflow Dynamics Inc. | Biodegradable coating with inhibitory properties for application to biocompatible materials |
| ES2155534T3 (es) * | 1994-10-12 | 2001-05-16 | Focal Inc | Administracion dirigida por medio de polimeros biodegradables. |
| US5690671A (en) | 1994-12-13 | 1997-11-25 | Micro Interventional Systems, Inc. | Embolic elements and methods and apparatus for their delivery |
| US5599326A (en) * | 1994-12-20 | 1997-02-04 | Target Therapeutics, Inc. | Catheter with multi-layer section |
| US5695998A (en) | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
| US5554389A (en) * | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
| US5733337A (en) * | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
| US6171326B1 (en) | 1998-08-27 | 2001-01-09 | Micrus Corporation | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
| US5645558A (en) | 1995-04-20 | 1997-07-08 | Medical University Of South Carolina | Anatomically shaped vasoocclusive device and method of making the same |
| US5624461A (en) | 1995-06-06 | 1997-04-29 | Target Therapeutics, Inc. | Three dimensional in-filling vaso-occlusive coils |
| NO962336L (no) | 1995-06-06 | 1996-12-09 | Target Therapeutics Inc | Vaso-okklusiv spiral |
| US5853418A (en) | 1995-06-30 | 1998-12-29 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils (II) |
| US5582619A (en) * | 1995-06-30 | 1996-12-10 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils |
| US5743905A (en) | 1995-07-07 | 1998-04-28 | Target Therapeutics, Inc. | Partially insulated occlusion device |
| CA2186768C (en) | 1995-09-29 | 2000-12-12 | Pete Phong Pham | Anatomically shaped vasoocclusive devices |
| US5830879A (en) * | 1995-10-02 | 1998-11-03 | St. Elizabeth's Medical Center Of Boston, Inc. | Treatment of vascular injury using vascular endothelial growth factor |
| US6090063A (en) | 1995-12-01 | 2000-07-18 | C. R. Bard, Inc. | Device, system and method for implantation of filaments and particles in the body |
| US5823198A (en) | 1996-07-31 | 1998-10-20 | Micro Therapeutics, Inc. | Method and apparatus for intravasculer embolization |
| EP1378257B1 (en) | 1996-08-23 | 2008-05-14 | Cook Biotech, Inc. | Collagen-based graft prosthesis |
| US6007573A (en) * | 1996-09-18 | 1999-12-28 | Microtherapeutics, Inc. | Intracranial stent and method of use |
| US6530951B1 (en) * | 1996-10-24 | 2003-03-11 | Cook Incorporated | Silver implantable medical device |
| JPH10127647A (ja) | 1996-10-29 | 1998-05-19 | Kaneka Medics:Kk | 血管塞栓部材の押出具および塞栓部材−押出具組立体 |
| CA2273250C (en) | 1996-12-10 | 2008-01-29 | Cook Biotech, Inc. | Stent grafts containing purified submucosa |
| DE69734218T2 (de) | 1996-12-10 | 2006-07-06 | Purdue Research Foundation, West Lafayette | Gewebetransplantat aus der Magensubmukosa |
| ES2263185T3 (es) | 1996-12-10 | 2006-12-01 | Purdue Research Foundation | Biomaterial derivado de tejido hepatico de vertebrados. |
| JP4152444B2 (ja) | 1996-12-10 | 2008-09-17 | パーデュー・リサーチ・ファウンデーション | 新規な診断用具としての胃粘膜下組織 |
| US5733329A (en) * | 1996-12-30 | 1998-03-31 | Target Therapeutics, Inc. | Vaso-occlusive coil with conical end |
| US5891192A (en) * | 1997-05-22 | 1999-04-06 | The Regents Of The University Of California | Ion-implanted protein-coated intralumenal implants |
| JP4392866B2 (ja) | 1997-08-08 | 2010-01-06 | 株式会社カネカメディックス | 塞栓材料および医療用ワイヤー装置 |
| JP4355038B2 (ja) | 1997-09-01 | 2009-10-28 | 株式会社カネカメディックス | 血管塞栓用具 |
| US7070607B2 (en) | 1998-01-27 | 2006-07-04 | The Regents Of The University Of California | Bioabsorbable polymeric implants and a method of using the same to create occlusions |
| US20070093889A1 (en) * | 1999-01-27 | 2007-04-26 | Wu Benjamin M | Non-Fragmenting Low Friction Bioactive Absorbable Coils for Brain Aneurysm Therapy |
| WO1999044538A1 (en) * | 1998-01-27 | 1999-09-10 | The Regents Of The University Of California | Biodegradable polymer/protein based coils for intralumenal implants |
| US5935145A (en) * | 1998-02-13 | 1999-08-10 | Target Therapeutics, Inc. | Vaso-occlusive device with attached polymeric materials |
| US6015424A (en) * | 1998-04-28 | 2000-01-18 | Microvention, Inc. | Apparatus and method for vascular embolization |
| US6569179B2 (en) * | 1998-11-10 | 2003-05-27 | Scimed Life Systems, Inc. | Bioactive three loop coil |
| US6187024B1 (en) * | 1998-11-10 | 2001-02-13 | Target Therapeutics, Inc. | Bioactive coating for vaso-occlusive devices |
| WO2000032112A1 (en) * | 1998-12-01 | 2000-06-08 | Washington University | Embolization device |
| EP1156759A4 (en) * | 1999-01-27 | 2002-11-20 | Univ California | BIODEGRADABLE POLYMER PROTEIN-BASED SPIRALS FOR INTRALUMINAL IMPLANTS |
| US6280457B1 (en) * | 1999-06-04 | 2001-08-28 | Scimed Life Systems, Inc. | Polymer covered vaso-occlusive devices and methods of producing such devices |
| US20020168398A1 (en) * | 2001-03-06 | 2002-11-14 | Yves Delmotte | Elongated biopolymer structure containing fibrin |
| US6585754B2 (en) * | 2001-05-29 | 2003-07-01 | Scimed Life Systems, Inc. | Absorbable implantable vaso-occlusive member |
-
2001
- 2001-02-16 US US09/785,743 patent/US7070607B2/en not_active Expired - Lifetime
-
2002
- 2002-02-11 EP EP02706247A patent/EP1359953B1/en not_active Expired - Lifetime
- 2002-02-11 JP JP2002565649A patent/JP4630525B2/ja not_active Expired - Fee Related
- 2002-02-11 ES ES02706247T patent/ES2362718T3/es not_active Expired - Lifetime
- 2002-02-11 AT AT02706247T patent/ATE509644T1/de not_active IP Right Cessation
- 2002-02-11 EP EP07023965A patent/EP1900382A3/en not_active Withdrawn
- 2002-02-11 WO PCT/US2002/004105 patent/WO2002066091A2/en active Application Filing
- 2002-02-11 CA CA2437694A patent/CA2437694C/en not_active Expired - Fee Related
- 2002-02-11 AU AU2002240349A patent/AU2002240349A1/en not_active Abandoned
-
2005
- 2005-08-05 US US11/198,587 patent/US8388643B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4630525B2 (ja) | 2011-02-09 |
| JP2005526523A (ja) | 2005-09-08 |
| EP1900382A3 (en) | 2008-04-02 |
| US20060058835A1 (en) | 2006-03-16 |
| US8388643B2 (en) | 2013-03-05 |
| AU2002240349A1 (en) | 2002-09-04 |
| US20020040239A1 (en) | 2002-04-04 |
| WO2002066091A3 (en) | 2003-04-03 |
| EP1900382A2 (en) | 2008-03-19 |
| CA2437694A1 (en) | 2002-08-29 |
| ATE509644T1 (de) | 2011-06-15 |
| EP1359953A2 (en) | 2003-11-12 |
| CA2437694C (en) | 2012-09-04 |
| US7070607B2 (en) | 2006-07-04 |
| EP1359953B1 (en) | 2011-05-18 |
| WO2002066091A2 (en) | 2002-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2362718T3 (es) | Implantes poliméricos bioabsorbibles y un método de uso de los mismos para crear oclusiones. | |
| US6423085B1 (en) | Biodegradable polymer coils for intraluminal implants | |
| JP4751661B2 (ja) | 細胞に制御された炎症性応答を起こさせるための血管内装置 | |
| Murayama et al. | Bioabsorbable polymeric material coils for embolization of intracranial aneurysms: a preliminary experimental study | |
| US11337705B2 (en) | Polymeric electrospun embolization device and methods of use | |
| ES2391763T3 (es) | Dispositivo de embolización | |
| ES2251190T3 (es) | Hidrogel para el tratamiento terapeutico de aneurismas. | |
| US7361367B2 (en) | Adding microscopic porosity to the surface of a microcoil to be used for medical implantation | |
| US20030199887A1 (en) | Filamentous embolization device and method of use | |
| JP2006506171A (ja) | ナノファイバでできた塞栓装置 | |
| JP2011136189A (ja) | 生物学的、生物分解性若しくは合成重合体又は繊維が巻き付けられた体腔を閉塞するための金属製コイル | |
| JP2013535264A (ja) | 外科インプラント | |
| JP2002502659A (ja) | 付着したポリマー繊維を有する血管閉塞デバイス | |
| Reinges et al. | Bare, bio-active and hydrogel-coated coils for endovascular treatment of experimentally induced aneurysms: long-term histological and scanning electron microscopy results | |
| US9795388B1 (en) | Surface configuration of implantable devices to modify biological activity and related method | |
| JP2004261218A (ja) | 血管塞栓用組成物 | |
| JP4427636B2 (ja) | 人工栓塞物 | |
| JP2021023728A (ja) | 組織再生基材 | |
| Tuite et al. | Coils, Occluders, and Plugs | |
| Marbacher | Pathobiology of healing response after endovascular treatment of intracranial aneurysms–Paradigm shift from lumen to wall oriented therapy |